Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

Formoterol Fumarate

Approved 13 Dec 2022InhalationSolution

The FDA lists this product in 10 strengths and forms.

Official labelAsk Osler about it

Composition

Active ingredients: FORMOTEROL FUMARATE 0.02MG/2ML

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA215621.

Open Drugs@FDA

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Formoterol Fumarate
Drug class: Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics, Selective beta-2-adrenoreceptor agonists
Group: Corticosteroids
Route: Inhalation
Dosage form: Solution
Applicant: Wilshire Pharms Inc
Status: Prescription
FDA approval: 13 Dec 2022
Application: ANDA215621-001
RxCUI: 236216